[(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate

C26H36O11 — CID 46830146

IUPAC[(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate
SMILESCC(=O)O[C@H]1C[C@H](O)[C@H](C)[C@@H]2[C@H](OC(C)=O)[C@]34O[C@]3(C)C(=O)O[C@H]4/C=C(/C)C[C@H](O)[C@H](OC(C)=O)[C@]21C
InChIInChI=1S/C26H36O11/c1-11-8-17(31)21(34-14(4)28)24(6)18(33-13(3)27)10-16(30)12(2)20(24)22(35-15(5)29)26-19(9-11)36-23(32)25(26,7)37-26/h9,12,16-22,30-31H,8,10H2,1-7H3/b11-9-/t12-,16-,17-,18-,19-,20+,21-,22-,24-,25+,26-/m0/s1
InChIKeyVUYMPAPPUKPGMS-LTSYTUNSSA-N
MW524.56 g/mol
LogP0.97
Rot. Bonds3

About [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate

[(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate (PubChem CID 46830146) has the molecular formula C26H36O11 and a molecular weight of 524.56 g/mol. Its IUPAC name is [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate.

Molecular Properties

Compound Name[(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate
PubChem CID46830146
Molecular FormulaC26H36O11
Molecular Weight524.56 g/mol
Exact Mass524.23
IUPAC Name[(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate
SMILESCC(=O)O[C@H]1C[C@H](O)[C@H](C)[C@@H]2[C@H](OC(C)=O)[C@]34O[C@]3(C)C(=O)O[C@H]4/C=C(/C)C[C@H](O)[C@H](OC(C)=O)[C@]21C
InChIInChI=1S/C26H36O11/c1-11-8-17(31)21(34-14(4)28)24(6)18(33-13(3)27)10-16(30)12(2)20(24)22(35-15(5)29)26-19(9-11)36-23(32)25(26,7)37-26/h9,12,16-22,30-31H,8,10H2,1-7H3/b11-9-/t12-,16-,17-,18-,19-,20+,21-,22-,24-,25+,26-/m0/s1
InChIKeyVUYMPAPPUKPGMS-LTSYTUNSSA-N
XLogP0.97
TPSA158.19 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds3
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500524.56
LogP ≤ 50.97
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate?
The IUPAC name of [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate (CID 46830146) is [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate.
What is the SMILES notation for [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate?
The canonical SMILES for [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate is CC(=O)O[C@H]1C[C@H](O)[C@H](C)[C@@H]2[C@H](OC(C)=O)[C@]34O[C@]3(C)C(=O)O[C@H]4/C=C(/C)C[C@H](O)[C@H](OC(C)=O)[C@]21C.
What is the InChIKey of [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate?
The InChIKey is VUYMPAPPUKPGMS-LTSYTUNSSA-N. The full InChI is InChI=1S/C26H36O11/c1-11-8-17(31)21(34-14(4)28)24(6)18(33-13(3)27)10-16(30)12(2)20(24)22(35-15(5)29)26-19(9-11)36-23(32)25(26,7)37-26/h9,12,16-22,30-31H,8,10H2,1-7H3/b11-9-/t12-,16-,17-,18-,19-,20+,21-,22-,24-,25+,26-/m0/s1.
What are the key properties of [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate?
[(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate has a molecular weight of 524.56 g/mol, XLogP of 0.97, 3 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,2S,3S,4R,5S,7S,8R,9R,10S,12Z,14S,17S)-2,9-diacetyloxy-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.01,17.03,8]octadec-12-en-7-yl] acetate is sourced from PubChem (CID 46830146), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).